More than 10% of healthy people who develop severe COVID-19 produce misguided antibodies that attack the patient's own immune system.
Molecules from the venom of one of the world's largest spiders could be used to develop pain blockers for people with irritable bowel syndrome.
Sustained high use of antimicrobial medicines has been demonstrated in a five-year trend report released by the Australian Commission on Safety and Quality in Health Care.
Daily coffee consumption has been associated with improved survival in patients with metastatic colorectal cancer, according to a study led by Dana-Farber Cancer Institute.
A new report has revealed the unseen burden of non-melanoma skin cancer in Australia.
A Monash-led international study has found that pregnancy can delay the onset of multiple sclerosis symptoms by more than three years.
The study compared the two most common treatments used in the long-term medical management of the condition: the oral contraceptive pill and metformin.
A trial has found that heart attacks and the need for coronary stenting or bypass surgery reduced by 30% in patients taking low-dose colchicine, a drug commonly used to treat gout.
CSL Limited has signed a heads of agreement for the supply of UQ's COVID-19 vaccine candidate and another to manufacture Oxford University's candidate.
Face shields are comfortable to wear — they're also re-usable, and can easily be disassembled and cleaned with most cleaning products.
Delays in the diagnosis and treatment of illnesses during COVID-19 may lead to a rise in preventable deaths in Australia, warns Alison Verhoeven, CE of AHHA.
Associate Professor Paul Griffin explains the different phases of the clinical trial process.
Dr Amy Cain and her colleagues have designed an antimicrobial peptide that holds promise for the future treatment of drug-resistant bacteria.
The Australian Government has released findings from the investigation into the spread of COVID-19 at Sydney aged-care facility Newmarch House.